ScreenCancer Awarded Support for Diagnostic Triage Algorithm-Project

DeepX Health is pleased to announce that daughter-company ScreenCancer has been awarded support from Innovation Norway for its Diagnostic Triage Algorithm-project. The project’s ambition is to streamline ScreenCancer’s teledermatology service for skin cancer in pharmacies by triaging skin lesions using a skin cancer algorithm in order to reduce time spent by dermatologists upon analysis and to reduce human error. The algorithm to be used is a new specification of Balter Medical's DermoSight algorithm. This project therefore demonstrates the synergies within DeepX Health.

We are very grateful for the support given to us, and proud to share the acknowledgement of our work. We are excited to discover the effects of the project, and will provide an update once the results are clear!

March 30, 2021

New Head of Product at DeepX Health

Read more

March 15, 2021

DeepX Health selected to present at Nordic Life Science Days

Read more

December 15, 2020

Pharmacy Screening Demonstrates Great Efficiency and Potential for Cost Reductions

Read more

October 23, 2020

Primary Care Setting Pilot Launched with NHS

Read more

October 14, 2020

DeepX Health to Present at the 8th World Congress of Teledermatology, Imaging and Artificial Intelligence for Skin Diseases

Read more

January 8, 2020

DeepX Health to participate at the 7th Annual Dermatology Summit in San Francisco

Read more

December 13, 2019

DeepX Health to present at Digital Health World Congress in London

Read more

December 3, 2019

DeepX Health participate in the DxPx Conference

Read more

December 1, 2019

ScreenCancer approved for first round of Horizon 2020 programme

Read more